A recent study from the University of California, Riverside sheds light on how SARS-CoV-2 may target human embryos at the earliest stages of development. The research suggests that cells in the first days after fertilization could be susceptible to infection, raising important questions about the virus's impact on pregnancy and fetal development. This Q&A explores the findings, implications, and what they mean for future research.
What does the UC Riverside study reveal about early human embryos and SARS-CoV-2?
The study shows that cells from the very earliest stages of human development — specifically the embryonic stage shortly after fertilization — can be infected by SARS-CoV-2. Using laboratory models, researchers found that these cells express the ACE2 receptor and TMPRSS2 protease, both of which are key entry points for the virus. This suggests that the virus may be able to invade the early embryo, potentially interfering with normal development. The findings provide a new perspective on how COVID-19 might affect pregnancy, especially during the critical first weeks when the embryo is implanting and beginning to form key structures.
Why are early embryonic cells considered vulnerable to infection?
Early embryonic cells are particularly vulnerable because they actively express high levels of ACE2, a protein that the SARS-CoV-2 spike protein binds to in order to enter host cells. Additionally, these cells produce TMPRSS2, an enzyme that helps the virus fuse with the cell membrane. This combination makes the embryo a potential target. Unlike many adult cells, which may have protective mechanisms or lower ACE2 levels, the early embryo appears to present an open door for the virus. The study suggests that vulnerability is highest during the first week of development, when the embryo is still free-floating before implantation.
How might SARS-CoV-2 infection affect pregnancy if early embryonic cells are infected?
If the virus infects early embryonic cells, it could disrupt critical processes like cell division, differentiation, and implantation. An infected embryo might fail to develop properly, leading to miscarriage or developmental abnormalities. However, it's important to note that the study is preliminary and does not prove that infection occurs in real pregnancies. The findings emphasize that the first few weeks are a delicate window. Even a mild infection of a few cells could have cascading effects as the embryo grows. The research highlights the need for more studies on how COVID-19, especially during early pregnancy, may impact fetal outcomes.
What does this mean for pregnant individuals concerned about COVID-19?
While the study raises awareness, it does not change current medical guidelines. Pregnant individuals should continue following standard precautions: vaccination, masking in high-risk settings, and seeking medical care if symptoms arise. The research underscores that early pregnancy — even before a person knows they are pregnant — may be a vulnerable period. Therefore, preventing infection in women of reproductive age is crucial. The study does not suggest that most pregnancies are in danger, but it provides a biological mechanism that could explain why some studies have associated COVID-19 with increased risk of pregnancy complications.
How does this research relate to other studies on COVID-19 and pregnancy?
Previous studies have shown that COVID-19 during pregnancy increases risks of preterm birth, preeclampsia, and stillbirth, but the mechanisms were unclear. This study offers a possible explanation: if the virus directly infects the early embryo, it could trigger inflammation or impair development. Other research has found ACE2 expression in placental tissues later in pregnancy, but this is one of the first to look at the pre-implantation embryo. It bridges a gap in understanding how SARS-CoV-2 could affect pregnancy from its very start, though much more work is needed to confirm these findings in living humans.
What are the next steps for this research?
The UC Riverside team plans to investigate how the virus actually behaves inside early embryonic cells, including whether it can replicate and cause cell death. They also want to study if different variants of SARS-CoV-2 vary in their ability to infect embryos. Additionally, they hope to collaborate with fertility clinics to study embryos donated for research. The ultimate goal is to understand the real-world risk and to develop strategies to protect embryos, such as potential antiviral treatments or vaccines that are safe during early pregnancy. The research is still in its early stages, but it opens a new avenue for protecting maternal and fetal health.